ULTRASOUND DETECTION OF VAULT HEMATOMA FOLLOWING VAGINAL HYSTERECTOMY

Citation
Ajm. Thomson et al., ULTRASOUND DETECTION OF VAULT HEMATOMA FOLLOWING VAGINAL HYSTERECTOMY, British journal of obstetrics and gynaecology, 105(2), 1998, pp. 211-215
Citations number
19
Categorie Soggetti
Obsetric & Gynecology
ISSN journal
03065456
Volume
105
Issue
2
Year of publication
1998
Pages
211 - 215
Database
ISI
SICI code
0306-5456(1998)105:2<211:UDOVHF>2.0.ZU;2-5
Abstract
Objective To assess whether ultrasound detection of vault haematoma ca n be used as a predictor of post-operative morbidity following vaginal hysterectomy. Design Prospective observational study of consecutive c ases of vaginal hysterectomy performed between 1991 and 1994. Sample T wo hundred and twenty-three women having undergone vaginal hysterectom y. Methods All women had transvaginal ultrasound examination by an ind ependent observer on the third post-operative day. Routine observation s and clinical assessments were made by established management protoco l, by staff blinded to the ultrasound findings. Main outcome measures Febrile morbidity; haemoglobin drop; need for blood transfusion; lengt h of stay in hospital; re-admission rate and length of stay. Results O f the 223 scanned women, 55 (25%) had a vault haematoma. This group wa s compared with the 168 women with no haematoma. Significant increases in febrile morbidity (31% vs 7%), post-operative haemoglobin drop (2. 5 g/dL vs 1.6 g/dL), need for blood transfusion (14.5% vs 1.2%), repre sentation to hospital (25.5% vs 5.4%) and length of hospital stay (8.8 7 days vs 6.25 days) were seen in the haematoma group. Conclusion Ultr asound detection of vault haematoma following vaginal hysterectomy is a common finding associated with increased febrile morbidity, need for blood transfusion, longer hospital stay and higher re-admission rate. In view of increasing demand for early discharge, driven by purchaser s and patients, post-operative ultrasound identifies a high risk popul ation and is both convenient and noninvasive. To further reduce morbid ity, it also offers the opportunity to perform a controlled trial of p rophylactic antibiotics in this identified subset.